Show simple item record

dc.contributor.authorGoswami, Pushpendra
dc.contributor.authorKhatib, Yasmin
dc.contributor.authorSalek, Sam
dc.date.accessioned2019-11-01T01:09:35Z
dc.date.available2019-11-01T01:09:35Z
dc.date.issued2019-04-01
dc.identifier.citationGoswami , P , Khatib , Y & Salek , S 2019 , ' Haematological malignancy: are we measuring what is important to patients? A systematic review of quality of life instruments ' , European Journal of Haematology , vol. 102 , no. 4 , pp. 279-311 . https://doi.org/10.1111/ejh.13203
dc.identifier.issn0902-4441
dc.identifier.otherPURE: 17632588
dc.identifier.otherPURE UUID: f4bda18e-e75a-4b94-bd23-109913608deb
dc.identifier.otherScopus: 85061618860
dc.identifier.urihttp://hdl.handle.net/2299/21835
dc.description© 2018 The Authors. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
dc.description.abstractThe wide range of health‐related quality‐of‐life (HRQoL) instruments used in haematology makes it challenging for haematologists and other care team members in practice to select, use and understand the scoring system and finally interpret the results. The main objectives of this study were to: (a) provide a comprehensive list of quality‐of‐life issues important to patients suffering from haematological malignancies, identified through the literature; (b) provide a list of health‐related quality‐of‐life (HRQoL) instruments used in haematological malignancies in both daily clinical practice and research; and (c) evaluate the relevance and comprehensibility of the identified instruments in haematological malignancies. Systematic literature review of two databases, followed by addition of articles by manual searching, was carried out. The articles focusing on the primary studies, which have used semi‐structured/structured interviews or surveys to identify issues important to HM patients, and other studies describing the results of testing measurement properties, such as reliability, validity and responsiveness of the instruments currently used to evaluate the HRQoL in different HMs, were included. Fifty‐seven studies reported development and validation of 30 HRQoL instruments, which have been used in haematology. Twenty‐four studies were identified using qualitative methods to report HRQoL issues and symptoms from a patient's perspective. No identified instrument captured all the issues identified from the qualitative studies. None of the instruments reviewed appeared to have been developed for use in clinical practice and specifically for patients with HM, except MyPOS. Furthermore, measurement properties were established, largely, in clinical trial scenarios. There is a need for development of a new HRQoL instrument entirely based on involvement of patients with haematological malignancies.en
dc.format.extent33
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Haematology
dc.subjectHRQoL
dc.subjectPRO
dc.subjectQoL
dc.subjectclinical practice
dc.subjectclinical research
dc.subjecthaematological malignancy
dc.subjectHematology
dc.titleHaematological malignancy: are we measuring what is important to patients? A systematic review of quality of life instrumentsen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPublic Health and Patient Safety Unit
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85061618860&partnerID=8YFLogxK
rioxxterms.versionVoR
rioxxterms.versionofrecordhttps://doi.org/10.1111/ejh.13203
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record